Related references
Note: Only part of the references are listed.Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
Anthony L. Cunningham et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults
Judith Falloon et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses
Judith Falloon et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels
Marloes Vissers et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults
Myron J. Levin et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
A. L. Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant
Judith Falloon et al.
VACCINE (2016)
Advances in RSV vaccine research and development - A global agenda
Deborah Higgins et al.
VACCINE (2016)
Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus
Sarah V. Maifeld et al.
PLOS ONE (2016)
Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus
Maximillian S. Habibi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults
Bindiya Bagga et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate
Bo Liang et al.
JOURNAL OF VIROLOGY (2015)
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Himal Lal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ebola vaccine R&D: Filling the knowledge gaps
Donata Medaglini et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques
Kathryn Patton et al.
VACCINE (2015)
A Novel Respiratory Syncytial Virus (RSV) F Subunit Vaccine Adjuvanted with GLA-SE Elicits Robust Protective TH1-Type Humoral and Cellular Immunity In Rodent Models
Stacie L. Lambert et al.
PLOS ONE (2015)
Dynamics of B cells in germinal centres
Nilushi S. De Silva et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Current concepts and progress in RSV vaccine development
Aleks K. Guvenel et al.
EXPERT REVIEW OF VACCINES (2014)
Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination
David Furman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Cell-mediated immune responses to respiratory syncytial virus infection Magnitude, kinetics, and correlates with morbidity and age
Bessey Geevarghese et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Adults 65 Years Old and Older Have Reduced Numbers of Functional Memory T Cells to Respiratory Syncytial Virus Fusion Protein
Anu Cherukuri et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections
N. Lee et al.
CLINICAL INFECTIOUS DISEASES (2013)
Neonatal Cytokine Profile in the Airway Mucosal Lining Fluid Is Skewed by Maternal Atopy
Nilofar V. Folsgaard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older Adults
Kyle Widmer et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
Mauricio A. Arias et al.
PLOS ONE (2012)
The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge
Grant C. Nicholson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults
Xu Yao et al.
VACCINE (2011)
The Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine versus 23-Valent Polysaccharide Vaccine in Adults Aged 50-80 Years
David Goldblatt et al.
CLINICAL INFECTIOUS DISEASES (2009)
Memory B cells: Effectors of long-lived immune responses
Stuart G. Tangye et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Immunological responses to pneumococcal vaccine in frail older people
I. Ridda et al.
VACCINE (2009)
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine
M. J. Levin et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
The immune geography of IgA induction and function
A. J. Macpherson et al.
MUCOSAL IMMUNOLOGY (2008)
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
MN Oxman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Risk factors for severe respiratory syncytial virus infection in elderly persons
EE Walsh et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults
EE Walsh et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies
PA Piedra et al.
VACCINE (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Share Paper
